Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival-A Nationwide Cohort Study from Finland.
Eerik E E SantalaMika O MurtoMiia ArtamaEero PukkalaKala VisvanathanTeemu J MurtolaPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
Inhibition of angiotensin receptor subtype 1 (AT1) could be a promising novel way to affect breast cancer progression.